TRIM28 and breast carcinoma: Therefore, we investigated whether TRIM28 knockdown would sensitize breast cancer cells to DNA-damaging agents: doxorubicin or γ-irradiation in vitro. A previous report regarding another drug, actinomycin D, demonstrated significant sensitization of breast cancer TRIM28-depeleted cells to chemotherapeutic agents compared with non-modified cells [15].